china biosimilar

Upload: uzair-ul-ghani

Post on 04-Apr-2018

230 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 China Biosimilar

    1/23

    Current Strategies for Cell Line Development

    Baisong Mei

    May 25, 2011

  • 7/30/2019 China Biosimilar

    2/23

    B. Mei, May 25, 2011 2

    Introduction

    Cell line development is one of the most critical steps inrecombinant protein manufacture

    - Process productivity Cost of Goods (COG)

    - Product quality, safety and efficacy

    Cell line can determine product comparability to themarketed counterpart

    Cell line development is time consuming and labor intensive

    Despite significant progress over the last 25 years, thescience of cell line development is still not well understood

  • 7/30/2019 China Biosimilar

    3/23

    B. Mei, May 25, 2011 3

    (Wurm, 2004, Nature Biotechnology)

    Significant Progress Achieved Over Last 25 Years

    Cell specific productivity increased from

  • 7/30/2019 China Biosimilar

    4/23

    B. Mei, May 25, 2011 4

    Processoptimization

    MolecularCloning

    Transfection/Electroporation

    Single CellCloning

    Drugselection

    Characteri-zation

    cGMP CellBanking

    Processes typically take 6-11 months depending host cell lines andnature of the recombinant proteins

    Some steps can be overlapped to save time and increase efficiency

    Cell Line Development Processes and Timeline

    Timeline (month)

    1-2

    0.5

    2-4

    0.5-11-2

    0.5-10.5

  • 7/30/2019 China Biosimilar

    5/23

    B. Mei, May 25, 2011 5

    Cell Line Development: Key Considerations

    Expression vector systems

    Host cell lines

    Cell clone selection

    Cell line characterization

    Process optimization

    Platform technologies and cGMP requirements

  • 7/30/2019 China Biosimilar

    6/23

    B. Mei, May 25, 2011 6

    Expression Vector Systems

    Selection markers

    - Dihydrofolate Reductase (DHFR)- Glutamine Synthetase (GS)

    - Antibiotics

    Promoters:- CMV

    - EF-1 alpha

    - Inducible promoters

    Other genetic elements:- Scalfold/Matrix Attachment

    Regions (S/MAR)

    - Chromotin opening elements

    - Locus control regions

    - Insulators

    - Viral terminal repeats

    Introns enhancing mRNA- Transcription

    - Processing

    - Export

    Vector of GOI

    758 3 bp

    Drug resistance gene

    GOI

    GOI 2

    Intron

    S/MAR

    S/MAR

    SV40 poly A

    bGH polyA

    CMV promoter

    EF-1a promoter

    pUC origin

  • 7/30/2019 China Biosimilar

    7/23B. Mei, May 25, 2011 7

    (Valencia et al, 2008, PNAS)

    Ratio of Cytoplasmicand Nuclear mRNA

    With Intron Without Intron

    FISH Analysis of -globin mRNA

    Intron: +

    Intron Facilitates mRNA Export

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265164/figure/F1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265164/figure/F1/
  • 7/30/2019 China Biosimilar

    8/23B. Mei, May 25, 2011 8

    Host Cell Lines

    Commonly used mammalian cell lines

    - CHO (Chinese hamster ovary)

    DHFR(-): DG44; DUKX B11

    DHFR(+): CHO-K1 and derivatives

    - NS0 (mouse myeloma)

    - BHK21 (baby hamster kidney)

    - HEK293 (human embryonic kidney) Other cell lines

    - PER.C6 (human embryonic retinal cells)

    - CAP (human amniocytes)

    - HKB11 (hybrid of HEK293 and human B cell)

    Host cell pre-adaptation

    Cell line engineering

    - Anti-apoptosis

    - Chaperones

    - DHFR knock out/knock down

    - GS knock out

  • 7/30/2019 China Biosimilar

    9/23B. Mei, May 25, 2011 9

    Targeted Gene Integration

    Currently introduction of transgene to host cell line is a randomintegration process

    Random integration can lead transgene to genomic area wheretranscription is not active or inhibited

    Targeted integration can guide transgene to the desired activegenomic area for maximum gene expression

    Ideal for stable, high level protein expression

    Human genomic sequence available human cell lines

    CHO genomic sequencing is becoming available

    Several targeted integration technologies available (in addition torecombinases)

    - Zinc finger nucleases

    - Meganucleases

    - Transcription activatorlike effector nucleases (TALEN)

  • 7/30/2019 China Biosimilar

    10/23B. Mei, May 25, 2011 10

    Gene Insertion

    Knock In

    Gene Inactivation

    Knock Out

    Involves site specific cleavage of genomic DNA by nuclease

    DNA binding domain provides specificity of the cleavage (forinsertion or inactivation)

    Can be used for gene knock in (targeted integration) as well asgene knock out (cell line engineering)

    Selection of integration sites (hot spots) remains challenging

    DNA CleavageDomain

    DNA BindingDomain ZFN (Sigma and

    Sangamo)

    Targeted Integration Technologies

  • 7/30/2019 China Biosimilar

    11/23B. Mei, May 25, 2011 11

    (Mei et al, 2006, Mol Biotechnology)

    Single Cell Cloning and Clone Selection

    A very small fraction of single cell clones provide high andstable expression

    Extensive cell line cloning and screening required

    Single Cell Clones

    Productivity

  • 7/30/2019 China Biosimilar

    12/23B. Mei, May 25, 2011 12

    Best Strategies To Select Single Cell Clones?

    Find a needle in a haystack what are the best strategies?

  • 7/30/2019 China Biosimilar

    13/23B. Mei, May 25, 2011 13

    Clone selection criteria

    - Productivity

    Cell specific productivity

    Volumetric productivity

    - Cell performance

    - Product quality

    Single Cell Cloning

    - Limited dilutions

    - FACS

    - ClonePix

    - LEAP

    Single Cell Cloning and Clone Selection

    http://www.bioexpress.com/mas_assets/image_cache/3/5/c/0/500x500_sku.t_3015_1_w.s_w.p.0.4_13760_file.jpeg
  • 7/30/2019 China Biosimilar

    14/23B. Mei, May 25, 2011 14

    http://www.genetix.com

    Single Cell Cloning Technologies

    ClonePix- Fluorescence label high

    producing cells

    - Desired single cell coloniespicked up by robotic arm

    LEAP

    - Laser Enabled Analysis and

    Processing- Fluorescence label high

    producing cells

    - Laser eliminates unwanted cells

    http://www.cyntellect.com

  • 7/30/2019 China Biosimilar

    15/23B. Mei, May 25, 2011 15

    (Chusainow et al, 2009, Biotechol Bioeng)

    Stable High Producing Cell Lines

    Cellular and molecular factors determine the quality of a cell line

    High gene copy number may not result in a high producer

    High producers usually produce high mRNA level

    Gene silencing (e.g. methylation) is one of major reasons for cell line instability

    Low producing clones High producing clones

    mRNALevel

    CopyNumber

  • 7/30/2019 China Biosimilar

    16/23B. Mei, May 25, 2011 16

    Intraclonal Heterogeneity

    (Pilbrough, Munro, Gray, 2009, PLoS One)

    Each single cell clone hasits own characteristics andinterclonal heterogeneity isexpected

    Single cell cloning isnecessary

    Cells from a clonal cell linecan also be heterorgeous

    Intraclonal heterogeneity iscaused by factors inaddition to cell size andcell cycle

    Intraclonal variation naynot be heritable

    Excessive rounds of singlecell cloning may not bebeneficial

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793030/figure/pone-0008432-g003/
  • 7/30/2019 China Biosimilar

    17/23B. Mei, May 25, 2011 17

    Cell Line and Product Quality

    Many product quality attributes are inherent from production cell line The attributes often can not be changed via process optimization

    Product comparability (quality) achieved early

    Analytical investment for cell line development heavy and early

    - Structure

    - Charge variants

    - Glycosylation

    N- and O-glycosylation

    Non-human glycans Neu5Gc, 1-3 alpha Gal

    - Other PTM (e.g. Sulfation, phosphorylation)

    - Aggregation

    - Biological activity- Productivity

    Justified PTM differences acceptable (safety, efficacy, consistency)

    Weighted ranking for clone selection

  • 7/30/2019 China Biosimilar

    18/23B. Mei, May 25, 2011 18

    (Costioli et al, 2010, BioPharm Intl)

    Cell Line Quality: Productivity vs COG

    Cost of goods (COG) perspective: COG distribution by unit operation for MAb manufacture

  • 7/30/2019 China Biosimilar

    19/23B. Mei, May 25, 2011 19

    (Modified from Strube et al, 2007, Bioseparation and Bioprocessing)

    COG Distributions vs. MAb Bioreactor Titer

    0

    1

    2

    3

    4

    5

    6

    0.1 0.3 1.0 5.0 10.0

    Bioreactor Titer (g/L)

    Unit

    ProductionCost

    0%

    20%

    40%

    60%

    80%

    100%

    120%

    %

    Distribution

    USP Other

    USP Other

    Cell Line Quality: Productivity vs COG

    Improvement of cell line productivity not always proportionallytranslated to COG reduction

    Product quality is one of the most important criteria for cell cloneselection

  • 7/30/2019 China Biosimilar

    20/23B. Mei, May 25, 2011 20

    Media and Upstream Process

    Media and fed strategies significantly improve productivity

    Several types of media may be necessary to support

    - Host cell maintanance

    - Transfection/cloning

    - Scale up

    - Production

    Evaluate and characterize final cell line candidates inbioreactor before preparing GMP cell bank

    (from Yu et al, 2011, Biotechnol. Bioeng.)

    Medium Feeds:

  • 7/30/2019 China Biosimilar

    21/23B. Mei, May 25, 2011 21

    Successful High Quality Cell Lines

    High QualityCell lines

    Product Quality

    Stability

    Cell Growth

    Scalability

    SpecificProductivity

    RobustnessExpression

    Vector

    UpstreamProcess

    Media Clone Selection

    Characterization

    Host Cell

  • 7/30/2019 China Biosimilar

    22/23B. Mei, May 25, 2011 22

    Platform Technologies and GMP Requirements

    Expression Vectors

    Host Cell Lines

    Cell Cloning

    Characterization

    Media and USP

    Platform technologies- Important for cell line quality

    - Improves process efficiency

    - Arrays of tools necessary

    - No one size fits all solution

    Front-loaded model

    - Invest upfront

    - Same cell line for clinical and commercial

    Guidelines and regulations from ICH andregulatory agencies

    cGMP compliance (documentation, Qualitycontrol, Quality and Regulatory inspectionand audit)

    Platform Tool Boxes

    http://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQhttp://www.google.com/imgres?imgurl=http://cdn.ifans.com/forums/imgcache3/f39860ba6df09f5c1f76ae59175e73b4.png%3Forig_url%3Dhttp://appaddict.net/wordpress/wp-content/uploads/2010/06/bookshelf_empty.png&imgrefurl=http://www.ifans.com/forums/showthread.php%3Ft%3D326805&usg=__cCNyOfWMXwUeqsc5EYmJZXDB3hk=&h=960&w=640&sz=875&hl=en&start=2&zoom=1&itbs=1&tbnid=nHMBPfpXeYwflM:&tbnh=148&tbnw=99&prev=/images%3Fq%3DEmpty%2Bbookshelf%26hl%3Den%26gbv%3D2%26tbm%3Disch&ei=PbarTf-3HIXJgQe71v2GCQ
  • 7/30/2019 China Biosimilar

    23/23

    Summary

    Cell line development is one of critical steps inmanufacture of protein therapeutics

    Multiple factors contribute to development of high qualitycell lines

    Product quality is one of the most important criteria for asuccessful cell line

    Employ new technologies available for cell linedevelopment

    Platform technologies can improve cell line quality and

    process efficiency